Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Ophthalmology

Protecting Your Corneas and Long-Term Monitoring

At a Glance

Atopic keratoconjunctivitis (AKC) requires lifelong monitoring to prevent severe corneal complications like keratoconus and shield ulcers. Regular eye exams tracking intraocular pressure and inflammation are essential to protect long-term vision and safely manage steroid use.

Because atopic keratoconjunctivitis (AKC) is a lifelong condition, the “win” isn’t just relieving today’s itch—it is protecting your sight for the decades to come. Chronic inflammation can slowly change the structure of your eye, making vigilant monitoring a non-negotiable part of your care plan [1][2].

Understanding Long-Term Corneal Risks

The cornea is the clear “windshield” of your eye. In AKC, constant inflammation can lead to several serious structural complications:

  • Keratoconus: This is a thinning and bulging of the cornea into a cone shape. While the exact cause is complex, frequent eye rubbing—often an irresistible response to intense AKC itching—is a major behavioral risk factor that drives this condition [3][4].
  • Recurrent Corneal Erosions (RCE): The chronic inflammation weakens the “glue” that holds the top layer of the cornea in place. This can cause the layer to slough off repeatedly, leading to sudden episodes of sharp pain and blurred vision, especially when waking up [5][6].
  • Shield Ulcers: These are deep, persistent sores on the cornea. They are a “red flag” emergency complication that can lead to permanent scarring and vision loss if they do not heal quickly [6][7].

The Importance of Surveillance

Regular monitoring with your ophthalmologist is critical for two primary reasons: intraocular pressure (IOP) and infection control.

  1. Pressure Checks (IOP): Many patients require topical steroids to manage sudden flares. However, chronic steroid use can cause a painless rise in eye pressure, leading to steroid-induced glaucoma and permanent nerve damage [8][9]. Using “steroid-sparing” agents like tacrolimus can help reduce this risk [9][10].
  2. Secondary Infections: AKC patients naturally have very high levels of Staphylococcus aureus (Staph) on their eyelids [11]. Because the ocular surface is already compromised by ongoing inflammation and sometimes mechanical scratching, these bacteria can easily invade the eye, causing severe secondary infections that worsen corneal damage [11][7].

A Proactive Monitoring Schedule

While your doctor will customize your schedule based on the severity of your disease, a standard monitoring plan often includes:

Frequency Action Item Purpose
Every 3–6 Months Comprehensive Slit-Lamp Exam To check for early signs of corneal scarring or inflammation [7].
Every Visit Intraocular Pressure (IOP) Check Vital for anyone using topical steroids to prevent glaucoma [8].
Annually Corneal Topography Specialized imaging to map the shape of the cornea and watch for early signs of keratoconus [12].
As Needed Eyelid Cultures If you have frequent “sties” or infections, to identify the specific bacteria (like Staph) [11].

Self-Monitoring at Home

You are the first line of defense. Pay close attention to “the 24-hour rule”: if you experience a sudden increase in pain, light sensitivity, or a drop in vision that does not improve within 24 hours of using your maintenance drops, contact your ophthalmologist immediately [13]. This is the most effective way to catch a shield ulcer or infection before it causes a permanent scar [6].

Common questions in this guide

Why do I need my eye pressure checked if I have AKC?
Many patients use topical steroids to manage flare-ups, which can cause a painless increase in eye pressure over time. Regular monitoring is essential because high pressure can lead to steroid-induced glaucoma and permanent nerve damage if left untreated.
What are shield ulcers in atopic keratoconjunctivitis?
Shield ulcers are deep, persistent sores on the cornea that result from severe chronic inflammation. They are considered a medical emergency and require immediate treatment to prevent permanent scarring and vision loss.
How does eye rubbing affect my corneas?
Frequent eye rubbing in response to intense itching physically traumatizes the eye. Over time, this mechanical stress is a major risk factor for keratoconus, a condition where the clear front layer of the eye thins and bulges outward.
What is the 24-hour rule for AKC symptoms?
The 24-hour rule advises that if you experience a sudden increase in eye pain, extreme light sensitivity, or a drop in vision that does not improve within a day of using your maintenance drops, you should contact your eye doctor immediately.
Are there steroid-free treatments for long-term AKC management?
Yes, ophthalmologists often use steroid-sparing medications like tacrolimus to manage chronic inflammation. These drops help control symptoms long-term while reducing the risks associated with prolonged steroid use, such as glaucoma.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my corneal topography, are there early signs of keratoconus or thinning that we should address now?
  2. 2.How often should my intraocular pressure (IOP) be measured given my current medication regimen?
  3. 3.What specific changes in my eyes should I report immediately as potential signs of a secondary Staph infection?
  4. 4.Can we use tear biomarkers or advanced imaging like corneal angiography to track my inflammation more objectively?
  5. 5.Is it time to discuss transitioning to a steroid-sparing medication like tacrolimus to reduce my long-term risks?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Atopic keratoconjunctivitis: A diagnostic dilemma-a case report.

    Li A, Li S, Ruan F, Jie Y

    Medicine 2018; (97(16)):e0372 doi:10.1097/MD.0000000000010372.

    PMID: 29668589
  2. 2

    Management of advanced ocular surface disease in patients with severe atopic keratoconjunctivitis.

    Jabbehdari S, Starnes TW, Kurji KH, et al.

    The ocular surface 2019; (17(2)):303-309 doi:10.1016/j.jtos.2018.12.002.

    PMID: 30528292
  3. 3

    Association between atopic keratoconjunctivitis and the risk of keratoconus.

    Weng SF, Jan RL, Wang JJ, et al.

    Acta ophthalmologica 2021; (99(1)):e54-e61 doi:10.1111/aos.14509.

    PMID: 32567209
  4. 4

    Epidemiological Association Between Systemic Diseases and Keratoconus in a Korean Population: A 10-Year Nationwide Cohort Study.

    Lee HK, Jung EH, Cho BJ

    Cornea 2020; (39(3)):348-353 doi:10.1097/ICO.0000000000002206.

    PMID: 31764280
  5. 5

    Association Between Atopic Keratoconjunctivitis and the Risk of Recurrent Corneal Erosion.

    Jan RL, Weng SF, Wang JJ, et al.

    Frontiers in medicine 2021; (8()):688355 doi:10.3389/fmed.2021.688355.

    PMID: 34150819
  6. 6

    Association between atopic keratoconjunctivitis and the risk of corneal ulcer.

    Jan RL, Weng SF, Wang JJ, et al.

    The British journal of ophthalmology 2021; (105(12)):1632-1637 doi:10.1136/bjophthalmol-2020-316206.

    PMID: 33011686
  7. 7

    Atopic keratoconjunctivitis with corneal ulcer. Case report.

    Zemba M, Burcea M, Camburu G

    Romanian journal of ophthalmology 2016; (60(3)):200-206.

    PMID: 29450349
  8. 8

    Pharmacotherapeutic management of atopic keratoconjunctivitis.

    Hossain IT, Sanghi P, Manzouri B

    Expert opinion on pharmacotherapy 2020; (21(14)):1761-1769 doi:10.1080/14656566.2020.1786534.

    PMID: 32602382
  9. 9

    Topical tacrolimus for allergic eye diseases.

    Erdinest N, Ben-Eli H, Solomon A

    Current opinion in allergy and clinical immunology 2019; (19(5)):535-543 doi:10.1097/ACI.0000000000000560.

    PMID: 31169598
  10. 10

    Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases.

    Yazu H, Fukagawa K, Shimizu E, et al.

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2021; (17(1)):11 doi:10.1186/s13223-021-00513-w.

    PMID: 33522964
  11. 11

    Transcriptome profiling of refractory atopic keratoconjunctivitis by RNA sequencing.

    Matsuda A, Asada Y, Suita N, et al.

    The Journal of allergy and clinical immunology 2019; (143(4)):1610-1614.e6 doi:10.1016/j.jaci.2018.11.007.

    PMID: 30471305
  12. 12

    Importance of Corneal Angiography in Subclinical Limbitis in a Case of Atopic Keratoconjunctivitis.

    Romano D, Coco G, Borgia A, et al.

    Cornea 2022; (41(8)):1038-1040 doi:10.1097/ICO.0000000000002891.

    PMID: 35266676
  13. 13

    Glycomics in tears: seeking for new biomarkers for ocular allergy diagnosis.

    Fauquert JL, Kowalski ML

    Allergy 2021; (76(8)):2335-2336 doi:10.1111/all.14846.

    PMID: 33825208

This page explains long-term monitoring strategies for atopic keratoconjunctivitis for educational purposes. Always consult your ophthalmologist to determine the safest management plan and monitoring schedule for your eyes.

Get notified when new evidence is published on Atopic keratoconjunctivitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.